Document:

Agreement dated March 27, 2003

 Exhibit 10.7 
  
 AGREEMENT 
  
 THIS AGREEMENT, effective this 27th day of March, 2003 (the “Effective Date”), is between COMMERCE BANK & TRUST COMPANY (the
“Bank”), a Massachusetts banking corporation with a principal place of business at 386 Main Street, Worcester, Massachusetts, and BOSTON BIOMEDICA, INC., a Massachusetts corporation with a principal place of business at 375 West Street,
West Bridgewater, Massachusetts (the “Borrower”). 
  
 STATEMENT OF FACTS 
  
 The Borrower is obligated to the
Bank as evidenced by the following documents: 
  
 1. Note dated
March 31, 2000 in the original principal amount of $2,900,000.00, executed by the Borrower in favor of the Bank; 
  
 2. Loan Agreement dated March 31, 2000, between the Borrower and the Bank (as it may have been amended and in effect from time to time, the “Loan
Agreement”); 
  
 3. Mortgage and Security Agreement dated
March 31, 2000, executed by the Borrower in favor of the Bank; 
  
 4. Collateral Assignment of Leases and Rents dated March 31, 2000, executed by the Borrower in favor of the Bank; and 
  
 5. Hazardous Materials Indemnification Agreement dated March 31, 2000 executed by the Borrower in favor of the Bank. 
  
 The foregoing documents, as they may have been amended, restated, superseded,
supplemented or modified from time to time, and any documents executed or delivered in connection therewith, are herein collectively referred to as the “Loan Documents.” The Bank is the holder of the Loan Documents. 
  
 The Borrower acknowledges that it is in default of its obligations under the
Loan Documents, and has requested that the Bank waive certain Defaults (defined below) with respect to the Loan Documents. 
  
 TERMS OF AGREEMENT 
  
 In consideration of the mutual promises contained in this Agreement, and other valuable consideration, the receipt and sufficiency of which are
acknowledged, the Bank and the Borrower agree as follows: 
  
 1.
Acknowledgment by the Borrower. The Borrower hereby acknowledges and agrees that the Borrower is in default of its obligations to the Bank under the Loan Documents, beyond any applicable periods of notice, cure or grace, and that the Borrower
has no defenses or off-sets that it could or would assert in the case of the Bank’s exercise of its rights and remedies thereunder. Specifically, the Borrower has (a) removed Richard Schumacher as its Chief Executive Officer without thirty days
prior written notice to the Bank (Section II.D.18 of the 

  

 
Loan Agreement); (b) failed to maintain a Debt Service Coverage Ratio (as defined in the Loan Agreement) of equal to or greater than 1.25 to 1.00 for the
year ending December 31, 2002 (Section II.X of the Loan Agreement); (c) failed to deliver to the Lender, within 45 days after the close of the fiscal quarter ending December 31, 2002, a balance sheet of the Borrower as of the close of that quarter,
and statements of income and retained earnings for that portion of the fiscal year to date then ended, prepared in conformity with GAAP and certified by the Borrower’s president or chief financial officer as accurate, true, and complete
(together, the “Reports”) (Section III.C.l.a of the Loan Agreement); and (d) on or about February 27, 2003, the Borrower adopted a shareholder purchase rights plan and has declared a distribution of one Right for each outstanding share of
the Borrower’s Common Stock (Sections II.D.4 and II.D.9 of the Loan Agreement) (collectively, the “Defaults”). The Borrower states that except for the Defaults there exist no other events of default as of the Effective Date. The
amounts due under the Loan Documents as of March 25, 2003, exclusive of attorneys’ fees and other costs of collection, are accurately set forth on Exhibit A. attached hereto. 
  
 2. Validity of the Loan Documents. The Borrower acknowledges that (a) the liabilities arising out of the Loan
Documents are the valid and binding obligations of the Borrower enforceable in accordance with their terms; (b) the liens, encumbrances, mortgages and security interests granted to the Bank pursuant to the Loan Documents remain valid, binding,
perfected and enforceable; and (c) the Bank may enforce the payment and performance of the obligations under the Loan Documents, as modified herein, and in accordance with applicable law, except to the extent the Bank has agreed to limit its rights
pursuant to this Agreement. The Bank reserves and does not waive any of its rights under the Loan Documents, the terms and conditions of which remain in full force and effect, except as specifically modified by this Agreement. 
  
 3. Representations and Warranties. In order to induce the Bank
to enter into this Agreement, the Borrower hereby affirms and restates as of the date hereof each of its representations and warranties contained in the Loan Documents, excepting representations and warranties concerning or affected by the
acknowledged Defaults above or amended or updated by the information provided in this Agreement, and excepting representations and warranties that speak to a particular date. 
  
 4. Waiver of Defaults. The Bank agrees to waive the Defaults. The waiver with respect to the Debt Service Coverage
Ratio is for the year ending December 31, 2002 only. The waiver with respect to the dividend adopted on or about February 27, 2003 is for that dividend only. This waiver shall not constitute or be deemed to be a waiver with respect to any
other terms or provisions of the Loan Documents or for any other periods. This waiver shall in no respect limit or diminish the rights and remedies of the Bank set forth in the Loan Documents with regard to any other condition or event now existing
or hereafter arising. 
  
 The Bank acknowledges that, other than
the Defaults, it is not aware of any other defaults of the Borrower’s obligations under the Loan Documents. Further, the Bank agrees that, in the event (a) that application of GAAP as determined by Borrower’s outside independent Certified
Public Accountants requires Borrower’s $1,000,000 loan receivable from Resort Accommodations International, LLC (“RAI”) and Richard T. Schumacher and evidenced by that certain Pledge and Security Agreement dated January 15, 2002 by and between Richard T. 

  

 2 

 
Schumacher, Borrower and the Bank and by that certain Junior Participation Agreement dated January 15, 2002 between and among the Bank, the Borrower, Richard
T. Schumacher and RAI (the “Loan Receivable”) to be reserved against, written down or written off as uncollectable (any such event being herein referred to as an “Adjustment”, and (b) Borrower thereafter fails to comply with the
financial covenant set forth in Section II.C.l3(a) and Section II.X (as amended by Allonge to Loan Agreement dated August 15, 2002) of the Loan Agreement, which failure would not exist if the Adjustment had not been made, then, notwithstanding the
provisions of Section II.C.13(a) and Section II.X (as amended by Allonge to Loan Agreement dated August 15, 2002) of the Loan Agreement, no Event of Default shall exist solely as a result thereof. The foregoing shall not constitute a waiver of any
other default or Event of Default which may exist or hereafter arise. 
  
 5. Agreements. The Borrower agrees: 
  

	 	(a)	to pay to the Bank a waiver fee (the “Waiver Fee”) of Fifty Two Thousand Dollars ($52,000.00) which will be fully earned on the Effective Date and paid in cash as follows:
(i) $13,000.00 on the Effective Date; (ii) $13,000.00 on or before April 18, 2003; (iii) $13,000.00 on or before May 19, 2003; and (iv) $13,000.00 on or before June 18, 2003; 

  

	 	(b)	to pay to the Bank on the Effective Date all reasonable costs incurred by the Bank in, connection with the negotiation, preparation, administration and enforcement of this Agreement
or the Loan Documents including the fees and expenses of Mirick, O’Connell, DeMallie & Lougee, LLP; and 

  

	 	(c)	to deliver to the Bank on or before the Effective Date an opinion from the Borrower’s attorneys, in form and substance acceptable to the Bank, opining that the Borrower is
authorized to enter into this Agreement. 

  
 6.
Modification of Loan Agreement. The Bank and the Borrower hereby agree that the Loan Agreement is hereby amended as follows: 
  
 Section III.C.I. is hereby amended to read as follows: 
  
 Financial Statements. Borrower shall deliver to the Lender (a) within forty-five (45) days after close of each of the fist three quarters of
each fiscal year of the Borrower, a balance sheet of the Borrower as of the close of each quarter and statements of income and retained earnings for that portion of the fiscal year-to-date then ended, prepared in conformity with GAAP and certified by the president or the chief financial officer of the Borrower as accurate, true and complete; and (b) within
ninety (90) days after the end of each fiscal year of Borrower, a consolidated balance sheet of the Borrower and its subsidiaries as of the end of such fiscal year and consolidated statements of income, shareholders’ equity and cash flow of the
Borrower and its subsidiaries for such fiscal year, in each case reported on by PricewaterhouseCoopers LLP or other independent certified public accountants of recognized national standing, which report shall express a positive opinion regarding the
fairness of the presentation of such financial statements in accordance with GAAP consistently applied. 
  

 3 

 Sections II.C.20(c)(i) and II.C.20(c)(ii) are hereby amended to read as follows: 
  
 (i) if the Borrower fails to comply with any of the covenants and
representations set forth in this Section II(C)(20); 
  
 (ii) if
at any time any representation or warranty made by the Borrower in this Section II(C)(20) shall be incorrect; 
  
 7. Release of Bank. Effective upon the execution of this Agreement by the Borrower, and in consideration of the Bank’s agreement to enter into
this Agreement, to the extent that the Borrower may have any off-sets, defenses or claims against the Bank or its subsidiaries, affiliates, parents, officers, directors, employees, agents, attorneys, predecessors, successors and assigns, both
present and former (collectively, the “Lender Affiliates”), the Borrower and its, subsidiaries, affiliates, officers, directors, heirs, successors, assigns, and executors, (collectively, the “Borrower Parties”), release, acquit
and forever discharge the Lender Affiliates of and from any and all manners of action and actions, cause and causes of action, suits, debts, controversies, damages, judgments, executions, claims and demands whatsoever asserted or unasserted, in
contract, tort, law or in equity which the Borrower Parties ever had or now have upon or against the Bank or any of them or the Lender Affiliates by reason of any matter, cause, causes or thing whatsoever existing on the Effective Date including,
without limitation, any presently existing claim or defense whether or not presently suspected, contemplated or anticipated and including but not limited to any claim that relates to, in whole or in part, directly or indirectly (i) the making or
administration of the loans evidenced by the Loan Documents, including, without limitation, such claims and defenses based on fraud, mistake duress, usury, misrepresentation, or any other claim based on so-called “lender liability
theories”; (ii) any covenants, agreements, duties, or obligations set forth in the Loan Documents; (iii) the actions or omissions of the Bank and/or the Lender Affiliates in connection with the initiation or continuing exercise of any right or
remedy contained in the Loan Documents or at law or in equity, (iv) lost profits; (v) loss of business opportunity; (vi) increased financing costs; (vii) increased legal or administrative fees; or (viii) damages to business reputation. 

 
 8. Scope of Agreement. The execution and delivery of this Agreement
constitutes the agreement by the Bank to waive the Defaults, but does not constitute (a) a waiver of any other default under the Loan Documents; or (b) an agreement to forbear on account of any other default under the Loan Documents or under this
Agreement, whether existing or which may occur subsequent to the Effective Date. 
  
 9. Payments. All payments required under this Agreement, including those for fees, costs, and expenses incurred by the Bank, shall be made when due in accordance with this Agreement and the Loan Documents as
modified, and to the extent available, may be debited directly from the Borrower’s demand deposit accounts at the Bank, without prior written notice to the Borrower or any other party. 
  
 10. Authority. The Borrower represents and warrants to the Bank that:
(a) all necessary corporate action on the part of the Borrower to be taken in connection with the execution, delivery and performance of this Agreement has been duly taken; and (b) the 

  

 4 

 
execution, delivery and performance by the Borrower of this Agreement (i) is within the authority of the Borrower, (ii) has been duly authorized by all
necessary corporate proceedings, (iii) does not conflict with or result in any breach or contravention of any provision of any law, statute, rule or regulation to which the Borrower is subject or any judgment, order, writ, injunction, license or
permit applicable to the Borrower, and (iv) does not conflict with any provision of the Borrower’s Articles of Organization or By-Laws. 
  
 11. Notices. Any notice, request, direction, consent, approval, waiver or other communication required or permitted under this Agreement to be sent
to the Bank must be in writing and will become effective only if provided (by mail or facsimile transmission) as follows: 
  

			
	Send original to:	  	 
	 	  	Commerce Bank & Trust Company
	 	  	386 Main Street
	 	  	Worcester, MA 01608
	 	  	Attn: Paul E. Lesniewski, Senior Vice President
	 	  	(508) 792-6795 (facsimile)
		
	with a copy to:	  	Mirick, O’Connell, DeMallie & Lougee, LLP
	 	  	100 Front Street
	 	  	Worcester, MA 01608
	 	  	Attn: Paul W. Carey, Esq.
	 	  	(508) 791-8502 (facsimile)

  
 Any notice, request,
direction, consent, approval, waiver or other communication required or permitted under this Agreement to be sent to the Borrower must be in writing and will become effective only if provided (by mail or facsimile transmission) addressed to the
Borrower at the following address: 
  

			
	Send original to:	  	 
	 	  	Boston Biomedica, Inc.
	 	  	375 West Street
	 	  	West Bridgewater, MA 02379
	 	  	Attn: Kevin Quinlan, President
	 	  	(508) 580-1110 (facsimile)
		
	with a copy to:	  	Brown Rudnick Berlack Israels LLP
	 	  	One Financial Center
	 	  	Boston, MA 02111
	 	  	Attn: Steven R. London
	 	  	(617) 856-8201 (facsimile)
	 	  	(617) 856-8313 (phone)

  

 5 

 12. Conflicting Provisions. If any conflict arises between the provisions of this Agreement and
the provisions of the Loan Documents, the provisions of this Agreement will prevail. All other provisions of the Loan Documents will remain in effect. 
  
 13. Negation of Partnership. The relationship between the Borrower and Bank is that of debtor and creditor. Nothing contained in this Agreement
will be deemed to create a partnership or joint venture between the Borrower and the Bank, or to cause the Bank to be liable or responsible in any way for the actions, liabilities, debts, or obligations of the Borrower. 
  
 14. Severability. If any clause or provision of this Agreement is
determined to be illegal, invalid or unenforceable under any present or future law by the final judgment of a court of competent jurisdiction, the remainder of this Agreement will not be affected thereby. It is the intention of the parties that if
any such provision is held to be invalid, illegal or unenforceable, there will be added in lieu thereof a provision as similar in terms to such provision as is possible, and that such added provision will be legal, valid and enforceable. 

 
 15. Headings. All headings contained in this Agreement are for
reference purposes only and are not intended to affect in any way the meaning or interpretation of this Agreement. 
  
 16. Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original document, but all of which will
constitute a single document. This document will not be binding on or constitute evidence of a contract between the parties until such time as a counterpart of this document has been executed by each of the parties and a copy thereof delivered to
each party under this Agreement. 
  
 17. Amendment. Neither
this Agreement nor any of the provisions hereof can be changed, waived, discharged or terminated, except by an instrument in writing signed by the parties against whom enforcement of the change, waiver, discharge or termination is sought.

  
 18. Governing Law. This Agreement will be interpreted
and construed under the laws of the Commonwealth of Massachusetts, regardless of the domicile of any party, and will be considered to have been made, executed and performed in Worcester County, Massachusetts. All claims, disputes and other matters
in question arising out of this Agreement will be decided by proceedings instituted and litigated in a court of competent jurisdiction sitting in Worcester County, Massachusetts. 
  
 19. Consent to Jurisdiction; Waivers. THE BORROWER HEREBY IRREVOCABLY AND UNCONDITIONALLY (A) SUBMITS TO PERSONAL
JURISDICTION IN THE COMMONWEALTH OF MASSACHUSETTS OVER ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OF THE LOAN DOCUMENTS, AND (B) WAIVES ANY AND ALL PERSONAL RIGHTS UNDER THE LAWS OF ANY STATE (I) TO THE RIGHT,
IF ANY, TO TRIAL BY JURY, (II) TO OBJECT TO JURISDICTION WITHIN THE COMMONWEALTH OF MASSACHUSETTS OR VENUE IN ANY PARTICULAR FORUM WITHIN THE COMMONWEALTH OF MASSACHUSETTS, AND (III) TO THE RIGHT, IF ANY, TO CLAIM OR RECOVER ANY SPECIAL, EXEMPLARY,
PUNITIVE OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES OTHER THAN ACTUAL DAMAGES. 
  

 6 

 EXECUTED as a sealed instrument effective as of the day and year first above written. 
  

					
	 COMMERCE BANK & TRUST COMPANY

			
	 	 	 	 	/s/    PAUL E. LESNIEWSKI,
SVP        
	 By:
	 	 	 	Paul E. Lesniewski
	 Its:
	 	 	 	Senior Vice President

  

					
	BOSTON BIOMEDICA, INC.
			
	 	 	 	 	/s/    KEVIN W.
QUINLAN        
	 By:
	 	 	 	Kevin W. Quinlan
	 Its:
	 	 	 	President & COO

  

 7 

 EXHIBIT A 
  
 Principal and Interest as of March 25,2003: 
  
 Principal: $2,360,217.02 
  
 Interest: $15,915.26$2,900,00 Note dated March 31, 2000

 Exhibit 10.8 
  
 NOTE 
  

					
	$2,900,000.00	 	 	  	March 31, 2000
	 	 	 	  	Worcester, Massachusetts

  
 FOR VALUE RECEIVED,
the undersigned, Boston Biomedica, Inc., a corporation organized pursuant to the laws of the Commonwealth of Massachusetts with a principal place of business at 375 West Street, West Bridgewater, Massachusetts (hereinafter called the
“Borrower”), promises to pay to 
  
 COMMERCE BANK
& TRUST COMPANY 
  
 a Massachusetts Trust Company organized pursuant to
Massachusetts General Laws, Chapter 172 (hereafter referred to as the “Lender”), OR ORDER at its principal office at 386 Main Street, Worcester, Worcester County, Massachusetts, 01608 the principal sum of 
  
 Two Million Nine Hundred Thousand and 00/100 ($2,900,000.00) DOLLARS

  
 or the aggregate unpaid principal amount of all advances made by the Lender to
the Borrower pursuant to the terms of the Agreement (as defined below), whichever is less together with interest on the unpaid principal until paid at the rate and in the manner hereafter provided in lawful money of the United States of America. The
principal of this Note shall bear interest computed on the basis of the actual number of days elapsed over a year of three hundred sixty (360) days. 
  
 Principal and interest not paid when due shall bear interest at the rate set forth herein from the due date until paid. 
  
 During the first five (5) years of this Note, the rate of interest payable
hereunder shall be nine and three quarters (9.75%) percent per annum. At the sixth (6th) anniversary of this Note,
interest shall be payable hereunder at the per annum rate of seven quarters of one (0.75%) percent in excess of the Corporate Base Rate then in effect. Corporate Base Rate shall mean the annual rate of interest established by the Lender from time to
time as its corporate base rate. 
  
 Equal payments of principal
and interest, on the outstanding principal, shall be paid monthly in arrears beginning one (1) month from the date hereof and continuing on the same day of each month thereafter until paid in full. Notwithstanding the foregoing, Lender may adjust
the monthly payments of principal and interest annually, each change to be effective with the next monthly payment, to insure that the monthly payments will continue to result in payment in full of the obligations of the Borrower hereunder assuming
an amortization term of twenty (20) year(s) from the date of the Note, the then applicable interest rate, and the balance of principal then outstanding, all to be determined by the Lender in its exclusive discretion exercised in a commercially
reasonable manner. 
  
 All indebtedness, if not sooner paid, shall
be due and payable ten (10) year(s) from the date of this Note. 
  

 1 

 The Lender may collect a late charge not to exceed five (5%) percent of any installment of principal or
interest, or any other amount due to the Lender which is not paid or reimbursed by the Borrower within fifteen (15) days of the due date thereof. 
  
 In addition to such late charge, after an Event of Default, that is not cured within any specified grace period, at the option of the Lender, the rate of
interest payable hereunder may be increased by four (4%) percent per annum. 
  
 The Borrower shall have the right to prepay this Note in part or in full without penalty, except that, if this Note is prepaid through financing with another lending institution, (i) during the first twelve months of
this Note additional interest in the amount of five percent (5%) of the amount prepaid shall be paid to the Lender, (ii) during the second twelve (12) months of this Note additional interest in the amount of four percent (4%) of the amount prepaid
shall be paid to the Lender, (iii) during the third twelve (12) months of this Note additional interest in the amount of three percent (3%) of the amount prepaid shall be paid to the Lender, (iv) during the fourth twelve (12) months of this Note
additional interest in the amount of two percent (2%) of the amount prepaid shall be paid to the Lender, (v) during the fifth twelve (12) months and any remaining period of this Note additional interest in the amount of one percent (1%) of the
amount prepaid shall be paid to the Lender. 
  
 Borrower shall
maintain with Lender an account from which Lender shall deduct the monthly payment due under, the Note. 
  
 This Note has been executed and delivered in accordance with the Loan Agreement (the “Agreement”) of even date herewith between the Borrower and
the Lender, incorporated herein by reference, which sets forth further terms and conditions upon which the entire unpaid principal hereunder and all interest hereon may become due and payable, and generally as to further rights of the Lender and
duties of the Borrower with respect hereto. 
  
 This Note shall
become due and payable, including the entire balance of principal and interest then accrued and unpaid, prior to maturity at the option (exercisable without notice and regardless of any prior forbearance or indulgences) of the holder hereof upon any
one or more of the following events, the occurrence of any of which shall be a default: 
  
 1. default in the performance or observance of any of the agreements, covenants or conditions of this Note or contained in any instrument securing this Note (other than payments due hereunder) or in any other
obligation of Borrower to the Lender or any other lender of Borrower; or 
  
 2. failure to make any payment due hereunder; or 
  
 3. institution of bankruptcy or insolvency proceedings by or against the Borrower, or any endorser or guarantor not discharged within thirty (30) days after the filing thereof; or 
  

 2 

 4. death, dissolution, termination of existence, insolvency or business failure of the Borrower; or

  
 5. appointment of a receiver of any part of the property of
any party to the Note, levy on or attachment of any property of any such party, or an assignment for the benefit of creditors by any such party, which is not cured within sixty (60) days. 
  
 Any deposits or other sums at any time credited by or due from the holder to Borrower or any endorser or guarantor hereof
and any securities or other property of Borrower or any endorser or guarantor hereof in the possession or custody of the holder may at all times be held and treated as collateral security for the payment of this Note and any and all other
liabilities, direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, of said respective Borrower, endorser or guarantor to the holder; and the holder on or after default in payment hereof may sell any
such securities or other property at broker’s board or at public sale or private sale without demand, notice or advertisement of any kind, all of which are hereby expressly waived. The holder may apply or set off such deposits or other sums
against said liabilities at any time in the case of Borrower, but only with respect to matured liabilities in the case of endorsers or guarantors. In case this Note shall not be paid in full whenever it shall become due, the Borrower and any
endorser or guarantor hereof agree to pay all costs and expenses of collection including court costs and reasonable attorneys’ fees. 
  
 Each Borrower, guarantor, endorser or other person now or hereafter liable for the payment of any of the indebtedness evidenced by this Note (herein a
“party”) severally agrees, by making, guaranteeing or endorsing this Note or by making any agreement to pay any of the indebtedness evidenced by this Note, to waive presentment for payment, protest and demand, notice of protest, demand and
of dishonor and non-payment of this Note, and consents without notice or further assent (a) to the substitution, exchange, or release of the collateral securing this Note or any part thereof at any time; (b) to the acceptance by the holder or
holders at any time of any additional collateral or security or other guarantors of this Note; (c) to the modification or amendment at any time, and from time to time, of this Note, and any instrument securing this Note, at the request of any person
liable hereon; (d) to the granting by the holder hereof of any extension of the time for payment of the Note or for the performance of the agreements, covenants, and conditions contained in this Note, or any instrument securing this Note, at the
request of any other person liable hereon; and (e) to any and all forebearances and indulgences whatsoever; and such consent shall not alter or diminish the liability of any person. 
  
 The Borrower represents that the proceeds of this Note will be used solely for commercial and business purposes and not for
personal, family, household or agricultural purposes and the Borrower acknowledges that this representation has been relied upon by the Lender. 
  
 This Note shall be the joint and several obligation of the Borrower and all sureties, guarantors and endorsers, and shall be binding upon them and their
respective successors and assigns and each or any of them. 
  

 3 

 IN WITNESS WHEREOF, the Borrower has signed and sealed this Note as of the day and year first above written. 

 

									
	 Signed in the presence of:
	 	 	 	 Boston Biomedica, Inc.

				
	/s/    Illegible        	 	 	 	 By:
	 	/s/    RICHARD T.
SCHUMACHER        
	Witness	 	 	 	 	 	Richard T. Schumacher,
its duly authorized Chief Executive Officer and
Assistant Treasurer

  

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]